Pages that link to "Q48191280"
Jump to navigation
Jump to search
The following pages link to Improved graft survival and striatal reinnervation by microtransplantation of fetal nigral cell suspensions in the rat Parkinson model. (Q48191280):
Displaying 50 items.
- Cellular replacement therapy for Parkinson's disease--where we are today? (Q28206557) (← links)
- Fibroblast growth factor (FGF)-2 and FGF receptor 3 are required for the development of the substantia nigra, and FGF-2 plays a crucial role for the rescue of dopaminergic neurons after 6-hydroxydopamine lesion (Q28507347) (← links)
- New developments in the surgery for Parkinson's disease (Q30580687) (← links)
- Characterisation of cell damage and death in embryonic mesencephalic tissue: a study on ultrastructure, vital stains and protease activity (Q30871360) (← links)
- Comparison of unilateral and bilateral intrastriatal 6-hydroxydopamine-induced axon terminal lesions: evidence for interhemispheric functional coupling of the two nigrostriatal pathways (Q32160990) (← links)
- Syringe needle skull penetration reduces brain injuries and secondary inflammation following intracerebral neural stem cell transplantation (Q33599129) (← links)
- The A9 dopamine neuron component in grafts of ventral mesencephalon is an important determinant for recovery of motor function in a rat model of Parkinson's disease (Q33656315) (← links)
- Transplantation in the rat model of Parkinson's disease: ectopic versus homotopic graft placement. (Q34120733) (← links)
- Reconstruction of the nigrostriatal pathway by simultaneous intrastriatal and intranigral dopaminergic transplants (Q34408115) (← links)
- The absence of CD47 promotes nerve fiber growth from cultured ventral mesencephalic dopamine neurons (Q34438025) (← links)
- Glial cell line-derived neurotrophic factor improves intrastriatal graft survival of stored dopaminergic cells (Q34455675) (← links)
- A multiple target neural transplantation strategy for Parkinson's disease (Q34982923) (← links)
- Regulation of dopamine cell type and transmitter function in fetal and stem cell transplantation for Parkinson's disease. (Q34997798) (← links)
- Transplantation site influences the phenotypic differentiation of dopamine neurons in ventral mesencephalic grafts in Parkinsonian rats (Q36263253) (← links)
- Adult human olfactory epithelial-derived progenitors: a potential autologous source for cell-based treatment for Parkinson's disease (Q36861593) (← links)
- Pharmacological enhancement of neuronal survival (Q37146138) (← links)
- Cellular immune response to intrastriatally implanted allogeneic bone marrow stromal cells in a rat model of Parkinson's disease (Q37236894) (← links)
- The fate of cell grafts for the treatment of Huntington's disease: the post-mortem evidence. (Q38168592) (← links)
- Feasibility of Three-Dimensional Placement of Human Therapeutic Stem Cells Using the Intracerebral Microinjection Instrument (Q38748322) (← links)
- Historical perspective of cell transplantation in Parkinson's disease (Q39429728) (← links)
- Bridging nigrostriatal pathway with fibroblast growth factor-primed peripheral nerves and fetal ventral mesencephalon transplant recuperates from deficits in parkinsonian rats (Q40205588) (← links)
- Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae (Q41173089) (← links)
- Nerve growth factors and the control of neurotransmitter phenotype selection in the mammalian central nervous system (Q41611970) (← links)
- Intrastriatal grafts of fetal mesencephalic cell suspensions in MPP -lesioned rats: a microdialysis study in vivo (Q42463556) (← links)
- Dopaminergic reinnervation of the globus pallidus by fetal nigral grafts in the rodent model of Parkinson's disease (Q42477973) (← links)
- Enhancement of sensorimotor behavioral recovery in hemiparkinsonian rats with intrastriatal, intranigral, and intrasubthalamic nucleus dopaminergic transplants. (Q42503701) (← links)
- Cell intrinsic and extrinsic factors contribute to enhance neural circuit reconstruction following transplantation in Parkinsonian mice. (Q42513881) (← links)
- Ectopic dopaminergic progenitor cells from En1( /Otx2lacZ) transgenic mice survive and functionally reinnervate the striatum following transplantation in a rat model of Parkinson's disease (Q43071868) (← links)
- Microencapsulated bovine chromaffin cell xenografts into hemiparkinsonian rats: a drug-induced rotational behavior and histological changes analysis (Q43543910) (← links)
- Microtransplantation of whole ganglionic eminence cells ameliorates motor deficit, enlarges the volume of grafts, and prolongs survival in a rat model of Huntington's disease (Q43664697) (← links)
- Restorative plasticity of dopamine neuronal transplants depends on the degree of hemispheric dominance. (Q43697260) (← links)
- Guidance of dopaminergic neuritic growth by immature astrocytes in organotypic cultures of rat fetal ventral mesencephalon (Q43864491) (← links)
- Diffusion parameters in the striatum of rats with 6-hydroxydopamine-induced lesions and with fetal mesencephalic grafts. (Q44211452) (← links)
- The release of excitatory amino acids, dopamine, and potassium following transplantation of embryonic mesencephalic dopaminergic grafts to the rat striatum, and their effects on dopaminergic neuronal survival in vitro (Q44272609) (← links)
- Cell Transplantation and Gene Therapy in Parkinson's Disease (Q44297524) (← links)
- Restorative potential of cholinergic rich transplants in cholchicine induced lesioned rats: a comparative study of single and multiple micro-transplantation approach (Q44462264) (← links)
- Angiogenic and neurotrophic effects of vascular endothelial growth factor (VEGF165): studies of grafted and cultured embryonic ventral mesencephalic cells (Q44535345) (← links)
- Effects of acetylcholinesterase and butyrylcholinesterase on cell survival, neurite outgrowth, and voltage-dependent calcium currents of embryonic ventral mesencephalic neurons (Q44668539) (← links)
- Dopaminergic neurons associate with blood vessels in neural transplants (Q44760131) (← links)
- The effects of transforming growth factor-beta2 on dopaminergic graft survival. (Q44931884) (← links)
- Survival and functional restoration of human fetal ventral mesencephalon following transplantation in a rat model of Parkinson's disease (Q45209471) (← links)
- Single-cell suspension methodology favors survival and vascularization of fetal striatal grafts in the YAC128 mouse model of Huntington's disease. (Q45293677) (← links)
- Multitract microtransplantation increases the yield of DARPP-32-positive embryonic striatal cells in a rodent model of Huntington's disease. (Q45300996) (← links)
- Microtransplantation of dopaminergic cell suspensions: further characterization and optimization of grafting parameters. (Q45981565) (← links)
- Combining neuroprotective treatment of embryonic nigral donor tissue with mild hypothermia of the graft recipient (Q46625527) (← links)
- Cytometric catheter for neurosurgical applications. (Q48270991) (← links)
- Co-grafted embryonic striatum increases the survival of grafted embryonic dopamine neurons (Q48393387) (← links)
- Translation of cell therapies to the clinic: characteristics of cell suspensions in large-diameter injection cannulae (Q48456297) (← links)
- Fibroblast growth factor 2 regulates dopaminergic neuron development in vivo (Q48547347) (← links)
- Temporal analysis of cytokine gene expression during infiltration of porcine neuronal grafts implanted into the rat brain (Q48553406) (← links)